Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)
Status:
Recruiting
Trial end date:
2024-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of Normobaric Hyperoxia
combined with intravenous thrombolysis for acute ischemic stroke.
Phase:
Phase 3
Details
Lead Sponsor:
Ji Xunming,MD,PhD
Collaborators:
Affiliated Hospital of Nantong University Beijing Friendship Hospital Beijing Shijitan Hospital, Capital Medical University Beijing Tongren Hospital Changsha Central Hospital Chengde Central Hospital Guizhou Provincial People's Hospital Jiangxi Provincial People's Hopital Jining First People's Hospital Jiujiang University Affiliated Hospital Liaocheng People's Hospital Linyi People's Hospital Nanyang Central Hospital People's Hospital of Beijing Daxing District Rizhao People's Hospital Second Affiliated Hospital of Nanchang University Shandong Provincial Hospital The Affiliated Hospital of Xuzhou Medical University The First Affiliated Hospital of Anhui Medical University The First Affiliated Hospital of Soochow University The First Affiliated Hospital of Zhengzhou University The Second Hospital of Anhui Medical University Tianjin Huanhu Hospital Zhumadian Central Hospital